GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Mechanical Regulation of Tumor Angiogenesis

$548,069
Cynthia A Reinhart-King · Vanderbilt University · R01 · FY2017 · HL

Overcoming primary and secondary resistance in wild-type BRAF melanoma

$548,033
Andrew E Aplin · Wistar Institute · P01 · FY2020 · CA

ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE

$547,729
Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2022 · DK

Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells

$547,720
Daniela E Matei · Northwestern University At Chicago · R01 · FY2020 · CA

Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma

$547,687
Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)

$547,685
Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2022 · CA

The EDRN Mesothelioma Biomarker Discovery Laboratory

$547,589
Harvey Ira Pass · New York University School Of Medicine · U01 · FY2020 · CA

Role of the stromal microenvironment in B-cell lymphoma progression and immune escape

$547,537
Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors

$547,532
Ankur Singh · Georgia Institute Of Technology · R01 · FY2025 · CA

Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level

$547,525
Warren Phipps · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes

$547,519
Ramon Francisco Barajas · Oregon Health & Science University · R37 · FY2024 · CA

Negative regulation of myeloid-derived suppressive cells in cancer

$547,478
Yulia Nefedova · Wistar Institute · R01 · FY2020 · CA

Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer

$547,420
Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2022 · CA

Metabolic Regulation ofPD-L1 in CD11c+ Cells

$547,418
Cong Yan · Indiana University Indianapolis · R01 · FY2019 · CA

Computational imaging approaches to personalized gastric cancer treatment

$547,185
Ruijiang Li · Stanford University · R01 · FY2024 · CA

Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system

$547,183
Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2025 · CA

Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system

$547,183
Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2022 · CA

Physical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments

$547,123
Lisa J McCawley · Vanderbilt University · U01 · FY2015 · CA

Targeting the vasculature to enhance anti-tumor immunity

$547,081
Andrew Carl Dudley · University Of Virginia · R01 · FY2025 · CA

Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens

$547,032
Rosalie C Sears · Oregon Health & Science University · U01 · FY2022 · CA

(PQC2) Localization as a determinant of cancer dormancy

$547,017
Charles P Lin · Massachusetts General Hospital · R01 · FY2015 · CA

A robust platform for multiplexed, subcellular proteomic imaging in human tissue

$547,000
Robert Michael Angelo · Stanford University · UH3 · FY2021 · CA

EZH2 in cancer biology and novel inhibitors

$546,990
Jun Qi · Dana-Farber Cancer Inst · R01 · FY2018 · CA

Ex vivo analysis of human brain tumor cells in a microvascular niche model

$546,939
Rong Fan · Yale University · R01 · FY2021 · CA

Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism

$546,896
Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA